Physician profile
Gary Y Okamura
NPI 1366542383
$69,359.88
in general payments reported to CMS, 2019-2025
14 companies · $12K in 2025
The $12K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,630 · 2020: $4,731 · 2021: $13K · 2022: $11K · 2023: $11K · 2024: $11K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $23K · Food and Beverage: $6,903 · Debt Forgiveness: $3,574 · Education: $77.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $23,004.53 |
| Food and Beverage | $6,903.42 |
| Debt Forgiveness | $3,573.90 |
| Education | $77.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $32,295.67 | 2021-2025 | Persona, Arcos, Comprehensive Shoulder System |
| Smith+Nephew, INC. | $17,787.76 | 2019-2025 | Q-Fix, Acufex Meniscal Root Repair, The Pink Hip Kit - Smith & Nephew Table |
| Arthrex, INC. | $6,083.11 | 2019-2022 | |
| Medical Device Business Services, INC. | $5,388.01 | 2019-2023 | Inhance |
| Johnson & Johnson Health Care Systems INC. | $3,573.90 | 2023 | |
| Stryker Corporation | $1,692.56 | 2022-2023 | Mako |
| Impactortho, INC. | $1,018.96 | 2022 | |
| Depuy Synthes Sales INC. | $874.61 | 2019-2024 | Attune, Na |
| Bioventus LLC | $392.89 | 2019-2023 | Supartz Fx Sodium Hyaluronate |
| Radius Health, INC. | $126.20 | 2019-2020 | |
| Team_makena_llc | $43.50 | 2019 | |
| Orthofix Medical, INC. | $34.41 | 2025 | Physio-Stim |
| Ethicon US, LLC | $24.54 | 2025 | Stratafix, Dermabond |
| Wright Medical Technology, INC. | $23.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Okamura listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.